Author:
Zhu Qianyu,Zhou Jialing,Li Hongyi,Wang Hui,Ren Jiangbo,Sun Shujie,Yang Miaoran,Wu Shanshan,Cao Ming,Wang Kaixiang,You Hong,Ma Hong
Funder
National Science and Technology Major Project
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference27 articles.
1. Bertino G, Neri S, Bruno CM et al (2011) Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med 102(5):363–371
2. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
3. Buti M, Gane E, Seto WK et al (2016) Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 1(3):196–206
4. Choi J, Kim GA, Han S et al (2019) Longitudinal assessment of three serum biomarkers to detect very early-stage hepatocellular carcinoma. Hepatology 69(5):1983–1994
5. Choi J, Kim GA, Han S et al (2020) Earlier alanine aminotransferase normalization during antiviral treatment is independently associated with lower risk of hepatocellular carcinoma in chronic hepatitis B. Am J Gastroenterol 115(3):406–414